{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-038408","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2023-10-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.995934+00:00","generated_at":"2026-06-09T08:20:35.410653+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"INVO Bioscience to merge with NAYA Biosciences in all-stock deal; NAYA shareholders to own 88%","bullets":["NAYA shareholders receive 7.33333 INVO shares per NAYA share, totaling ~18.15M shares.","Combined company to operate as NAYA Biosciences; Dr. Daniel Teper named Chairman & CEO.","Merger values INVO at $12.4M and NAYA at $90.8M; closing conditions include $5M+ interim PIPE and $5.00/share offering.","Transaction unanimously approved by both boards, expected to close in Q4 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-038408","json":"https://secwatch.observer/filing/0001493152-23-038408.json","markdown":"https://secwatch.observer/filing/0001493152-23-038408.md","text":"https://secwatch.observer/filing/0001493152-23-038408.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223038408/0001493152-23-038408-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223038408/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T08:20:35.410653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"770b94c95f94b1e20df39cfde70f0e4119af8498","claim":"INVO Fertility, Inc. entered into Agreement and Plan of Merger with NAYA Biosciences, Inc. (effective 2023-10-22).","evidence_excerpt":"On October 22, 2023, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”), INVO Merger Sub Inc., a wholly owned subsidiary of the Company and a Delaware corporation (“ Merger Sub ”), and NAYA Biosciences, Inc., a Delaware corporation (“ NAYA ”), entered into an Agreement and Plan of Merger, as amended on October 25, 2023 (collectively, the “ Merger Agreement ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223038408/0001493152-23-038408-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"NAYA Biosciences, Inc."},{"label":"Effective","value":"2023-10-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}